These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26456186)
1. Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection. Burrer CM; Foight GW; Keating AE; Chan GC Virus Res; 2016 Jan; 211():86-8. PubMed ID: 26456186 [TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells. Purushothaman P; Thakker S; Verma SC J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714 [TBL] [Abstract][Full Text] [Related]
3. Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus. Dollery SJ; Santiago-Crespo RJ; Kardava L; Moir S; Berger EA J Virol; 2014 Feb; 88(3):1748-57. PubMed ID: 24257608 [TBL] [Abstract][Full Text] [Related]
5. BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells. Cojohari O; Burrer CM; Peppenelli MA; Abulwerdi FA; Nikolovska-Coleska Z; Chan GC J Virol; 2015 May; 89(10):5739-46. PubMed ID: 25740993 [TBL] [Abstract][Full Text] [Related]
6. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections. Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906 [TBL] [Abstract][Full Text] [Related]
7. Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells. Chen L; Lagunoff M J Virol; 2005 Nov; 79(22):14383-91. PubMed ID: 16254372 [TBL] [Abstract][Full Text] [Related]
8. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. Punjabi AS; Carroll PA; Chen L; Lagunoff M J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100 [TBL] [Abstract][Full Text] [Related]
9. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. Sharp TV; Wang HW; Koumi A; Hollyman D; Endo Y; Ye H; Du MQ; Boshoff C J Virol; 2002 Jan; 76(2):802-16. PubMed ID: 11752170 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340 [TBL] [Abstract][Full Text] [Related]
11. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells. Holmes DL; Vogt DT; Lagunoff M Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441 [TBL] [Abstract][Full Text] [Related]
12. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969 [TBL] [Abstract][Full Text] [Related]
13. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388 [TBL] [Abstract][Full Text] [Related]
14. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation. Yang M; Huang L; Li X; Kuang E Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848 [TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. Viejo-Borbolla A; Schulz TF AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001 [TBL] [Abstract][Full Text] [Related]
16. Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus. Kati S; Hage E; Mynarek M; Ganzenmueller T; Indenbirken D; Grundhoff A; Schulz TF J Virol Methods; 2015 Jun; 217():79-86. PubMed ID: 25736227 [TBL] [Abstract][Full Text] [Related]
17. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan. Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946 [TBL] [Abstract][Full Text] [Related]
18. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824 [TBL] [Abstract][Full Text] [Related]
19. Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase. Xiang Q; Ju H; Li Q; Mei SC; Chen D; Choi YB; Nicholas J J Virol; 2018 Apr; 92(7):. PubMed ID: 29343584 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]